Back to results
US 2004/0006120 A1Published application
Use of histamine h3 receptor inverse agonists for the control of appetite and treatment of obesity
OwnerStephen L Yates, Clark E Tedford +1inventors
InventorsStephen L Yates, Clark E Tedford, Kurt R Brunden
Life of this patent
Estimating the term…
Abstract
A method for the use of histamine II3 receptor inverse agonists in the regulation of appetite and treatment of obesity is disclosed. Presently preferred inverse agonists are imidiazole derivatives.
Claims5
A method for promoting weight loss and treating eating disorders comprising administering to a patient in need of such weight loss or treatment an effective amount of an inverse agonist of histamine H3 receptors, with the proviso that said inverse agonist is not thioperamide.
Dependencies are inferred from the claim text.